Reckitt Benckiser Group plc (LON:RKT - Get Free Report) insider Tamara Ingram acquired 293 shares of the business's stock in a transaction on Wednesday, July 30th. The shares were bought at an average cost of GBX 5,626 ($74.60) per share, with a total value of £16,484.18 ($21,856.51).
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group stock traded down GBX 26 ($0.34) during midday trading on Thursday, reaching GBX 5,646 ($74.86). The company had a trading volume of 8,735,099 shares, compared to its average volume of 3,647,292. Reckitt Benckiser Group plc has a 12-month low of GBX 4,053 ($53.74) and a 12-month high of GBX 5,722 ($75.87). The company has a market capitalization of £38.52 billion, a P/E ratio of 25.84, a P/E/G ratio of 1.10 and a beta of 0.09. The firm's fifty day simple moving average is GBX 5,093.75 and its 200-day simple moving average is GBX 5,074.49. The company has a debt-to-equity ratio of 110.26, a current ratio of 0.69 and a quick ratio of 0.46.
Reckitt Benckiser Group (LON:RKT - Get Free Report) last announced its earnings results on Thursday, July 24th. The company reported GBX 141.20 ($1.87) EPS for the quarter. Reckitt Benckiser Group had a net margin of 10.78% and a return on equity of 18.70%. As a group, equities analysts anticipate that Reckitt Benckiser Group plc will post 331.2110727 EPS for the current year.
Wall Street Analyst Weigh In
Several equities research analysts have commented on the company. Royal Bank Of Canada upped their price target on Reckitt Benckiser Group from GBX 5,700 ($75.58) to GBX 6,000 ($79.55) and gave the stock an "outperform" rating in a research note on Thursday, July 24th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a GBX 5,300 ($70.27) price target on shares of Reckitt Benckiser Group in a report on Monday, July 21st.
Get Our Latest Research Report on Reckitt Benckiser Group
Reckitt Benckiser Group Company Profile
(
Get Free Report)
At Reckitt, we protect, heal and nurture. We are the company behind some of the world's best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we're all making a real difference to people all over the world, every day.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.